The global gene synthesis market is one of the most rapidly evolving life sciences sectors, owing to the ability to design and synthesize custom DNA. Gene synthesis involves chemically synthesizing strands of DNA based on a known sequence. It is used extensively in research activities for a wide variety of applications such as designing genes for molecular biology studies, non-natural molecules and biologics, as well as synthetic genes for viral modeling. The process is also finding increasing applications in engineering biological systems and developing engineered organisms. Custom gene synthesis helps accelerate the process of manufacturing DNA/RNA molecules for research and clinical uses. The global gene synthesis market is estimated to be valued at US$ 2.49 billion in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The growing demand for custom DNA across industries is a key factor propelling the expansion of the gene synthesis market. Researchers can design genes and genomic constructs based on specific scientific queries which helps advance the field of synthetic biology. Gene editing tools like CRISPR have increased synthetic DNA applications in developing engineered cell lines, transgenic animals and plants. As ongoing research activities utilize gene synthesis as a core technology, the potential clinical applications of synthesized genes and DNA would help drive market growth over the coming years.
SWOT Analysis
Strength: The Global gene synthesis market size has witnessed increasing adoption of gene synthesis services for developing therapeutic solutions such as cancer gene therapy and antiviral therapeutics. This is expected to drive the market growth during the forecast period.
Weakness: High cost associated with gene synthesis techniques limits their widespread adoption. Stringent regulations for gene synthesis may also hamper the market growth.
Opportunity: Increasing R&D investment by pharmaceutical and biotechnology companies into synthetic biology is expected to present lucrative opportunities. Growing demand for clinical applications provide new avenues.
Threats: Security issues related to the misuse of gene synthesized sequences is a major concern. Lack of skilled workforce and biosafety issues pose threats.
Key Takeaways
The global gene synthesis market is expected to witness high growth over the forecast period of 2023 to 2030.
Regional analysis: North America dominates the global gene synthesis market currently. Growing research activities in synthetic biology and adoption of advanced technologies in the US and Canada drives the North America market. Asia Pacific region is expected to grow at the fastest rate during the forecast period owing to increasing government support for R&D projects in countries such as China and India.
Key players: Key players operating in the gene synthesis market are Herb Pharm LLC, Apis Flora, Bee Health Limited, Y.S. Organic Bee Farms, Comvita Ltd, Wax Green, Apiary Polenecter, Uniflora Health Foods, Sunyata Pon Lee, NOW Foods, and Bio Botanica Inc. (Nature’s Answer). These players are focusing on enhancing their product portfolio through strategic collaborations and new product launches.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
